Virology
Showing 1 - 25 of 583
SARS-CoV-2 Infection Trial in Incheon (CT-P59)
Completed
- SARS-CoV-2 Infection
- CT-P59
-
Incheon, Korea, Republic ofIncheon Medical Center
Apr 6, 2022
D²EFT Graphical Informed Consent
Completed
- HIV-1-infection
- Graphical Informed Consent (GIC)
-
Abuja, NigeriaInstitute of Human Virology Nigeria (IHVN)
Jan 6, 2022
Heplisav-B Revaccination for Hepatitis B Vaccine Nonresponders
Completed
- HIV Infections
- +2 more
-
Baltimore, Maryland
- +1 more
Mar 17, 2023
Long-term Effectiveness of a Recombinant Hepatitis E Vaccine
Not yet recruiting
- Hepatitis E
- serology and virology detection of hepatitis E virus
-
Dongtai, Jiangsu, ChinaDongtai Center for Disease Control and Prevention
Jul 28, 2023
COVID-19 Respiratory Infection Trial in Tashkent (Rutan 25 mg, Control group)
Completed
- COVID-19 Respiratory Infection
- Rutan 25 mg
- Control group
-
Tashkent, UzbekistanTashkent Institute of Virology
May 16, 2023
COVID-19 Trial in United States (Ad26.COV2.S, BNT162b2, mRNA-1273)
Recruiting
- COVID-19
- Ad26.COV2.S
- +4 more
-
Atlanta, Georgia
- +11 more
Aug 11, 2022
HIV, AIDS Trial in Abuja (PEPFAR Enhanced Standard of Care (PESCA), Peer Transition Advocate (PTA))
Active, not recruiting
- HIV
- AIDS
- PEPFAR Enhanced Standard of Care (PESCA)
- Peer Transition Advocate (PTA)
-
Abuja, FCT, NigeriaInstitute of Human Virology, Nigeria
May 3, 2022
HPV Infection, HPV Vaccine Trial in Seattle (HPV vaccine)
Active, not recruiting
- HPV Infection
- HPV Vaccine
- HPV vaccine
-
Seattle, WashingtonUniversity of Washington Virology Research Clinic
Mar 4, 2022
Impact of the Covid-19 on RSV
Not yet recruiting
- Rhinovirus
- RSV Infection
- epidemiology
-
Lyon, France
- +1 more
Apr 27, 2022
Cardiovascular Diseases, Hepatitis C, Hiv Trial in Washington, Baltimore (Elbasvir / Grazoprevir Oral Tablet [Zepatier], Cardiac
Active, not recruiting
- Cardiovascular Diseases
- +2 more
- Elbasvir / Grazoprevir Oral Tablet [Zepatier]
- Cardiac MRI
-
Washington, District of Columbia
- +1 more
Feb 1, 2023
Chronic Hepatitis B Trial in Hamburg (HEPLISAV B; TherVacB, TherVacB)
Not yet recruiting
- Chronic Hepatitis B
- HEPLISAV B; TherVacB
- TherVacB
-
Hamburg, GermanyCTC North
Feb 3, 2023
Triage Test for All Oral DR-TB Regimen (TRiAD Study)
Recruiting
- Drug Resistant Tuberculosis
- +3 more
- Xpert® MTB/XDR
-
Gulele, Addis Ababa, Ethiopia
- +3 more
Jun 13, 2022
Asthma in Children, Dysbiosis Trial (Stool test, Blood test, Induced sputum)
Not yet recruiting
- Asthma in Children
- Dysbiosis
- Stool test
- +3 more
- (no location specified)
Jan 14, 2022
Hepatitis B Trial in Baltimore, Falls Church (Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B])
Withdrawn
- Hepatitis B
- Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B]
-
Baltimore, Maryland
- +1 more
Jul 19, 2022
Impact of the Covid-19 on RSV Epidemic in the Metropolis of Lyon
Not yet recruiting
- Rhinovirus
- RSV Infection in Children Less Than 5 Years of Age
- epidemiology
-
Lyon, France
- +1 more
Apr 26, 2022
Varicella Zoster Virus Infection Trial in Seattle (Shingrix)
Not yet recruiting
- Varicella Zoster Virus Infection
-
Seattle, WashingtonUniversity of Washington Virology Research Clinic
Jan 13, 2022
Monkeypox Trial in Puerto Rico, United States (JYNNEOS)
Not yet recruiting
- Monkeypox
- JYNNEOS
-
Birmingham, Alabama
- +13 more
Feb 13, 2023
Broadly HIV-1 Neutralizing Antibodies in HIV-infected Mbeya,
Active, not recruiting
- HIV/AIDS
-
Mbeya, TanzaniaNIMR-Mbeya Medical Research Center (MMRC)
Aug 5, 2022
HIV Trial in Baltimore (Nevirapine, FTC, and Tenofovir)
Completed
- HIV
- Nevirapine, FTC, and Tenofovir
-
Baltimore, MarylandUniversity of Maryland, Institute of Human Virology
Oct 28, 2021
Non-Alcoholic Steatohepatitis(NASH), Hepatitis C, Hepatitis B Trial in Buffalo
Recruiting
- Non-Alcoholic Steatohepatitis(NASH)
- +7 more
-
Buffalo, New YorkUniversity at Buffalo, Buffalo General Medical Center
Apr 15, 2022
HIV Trial in Baltimore (Lopinavir/Ritonavir)
Terminated
- HIV
-
Baltimore, MarylandUniversity of Maryland, Institute of Human Virology
Jan 20, 2022
HIV Trial in Baltimore (Switch to Maraviroc + Raltegravir or Dolutegravir)
Completed
- HIV
- Switch to Maraviroc + Raltegravir or Dolutegravir
-
Baltimore, MarylandUniversity of Maryland, Institute of Human Virology
Oct 5, 2021
HIV Trial in Baltimore (3TC, TDF, NLV)
Completed
- HIV Infections
- 3TC, TDF, NLV
-
Baltimore, Maryland
- +1 more
May 6, 2021
COVID-19, SARS-CoV-2 Trial in United States (Ascorbic Acid, Hydroxychloroquine Sulfate, Azithromycin)
Terminated
- COVID-19
- SARS-CoV-2
- Ascorbic Acid
- +4 more
-
Chicago, Illinois
- +5 more
Jul 12, 2022